These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11784252)

  • 21. A negative selection system PowerMag for effective leukocyte depletion and enhanced detection of EpCAM positive and negative circulating tumor cells.
    Lin HC; Hsu HC; Hsieh CH; Wang HM; Huang CY; Wu MH; Tseng CP
    Clin Chim Acta; 2013 Apr; 419():77-84. PubMed ID: 23415697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The significance of circulating tumor cells in head and neck squamous cell carcinoma: a preliminary study].
    Zhang HD; Gong SC; Liu YQ; Liang LJ; He SB; Zhang QX; Si MY; Yu ZK
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 53(1):39-44. PubMed ID: 29365378
    [No Abstract]   [Full Text] [Related]  

  • 23. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H; Pääkkö P; Turpeenniemi-Hujanen T
    Clin Cancer Res; 2005 May; 11(9):3257-64. PubMed ID: 15867221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p16INKa immunocytochemistry in fine-needle aspiration cytology smears of metastatic head and neck squamous cell carcinoma.
    Grimes R; Garcia-Buitrago MT; Jorda M; Ganjei-Azar P; Ferrell A; Gomez-Fernandez C
    Acta Cytol; 2013; 57(1):33-7. PubMed ID: 23221169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
    Partridge M; Phillips E; Francis R; Li SR
    J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma.
    Morimoto H; Yano T; Yoda Y; Oono Y; Ikematsu H; Hayashi R; Ohtsu A; Kaneko K
    World J Gastroenterol; 2017 Feb; 23(6):1051-1058. PubMed ID: 28246479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytologic detection of isolated tumor cells in bone marrow of patients with squamous cell carcinomas of the head and neck region.
    Gath HJ; Heissler E; Hell B; Bier J; Riethmüller G; Pantel K
    Int J Oral Maxillofac Surg; 1995 Oct; 24(5):351-5. PubMed ID: 8627101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
    Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Confocal laser endomicroscopy in head and neck malignancies using FITC-labelled EpCAM- and EGF-R-antibodies in cell lines and tumor biopsies.
    Englhard AS; Palaras A; Volgger V; Stepp H; Mack B; Libl D; Gires O; Betz CS
    J Biophotonics; 2017 Oct; 10(10):1365-1376. PubMed ID: 28106950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary investigation of circulating extracellular vesicles and biomarker discovery associated with treatment response in head and neck squamous cell carcinoma.
    Rodrigues-Junior DM; Tan SS; de Souza Viana L; Carvalho AL; Lim SK; Iyer NG; Vettore AL
    BMC Cancer; 2019 Apr; 19(1):373. PubMed ID: 31014274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
    Hristozova T; Konschak R; Budach V; Tinhofer I
    Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology.
    Jatana KR; Balasubramanian P; McMullen KP; Lang JC; Teknos TN; Chalmers JJ
    Head Neck; 2016 Dec; 38(12):1799-1803. PubMed ID: 27265898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumour cell PD-L1 test for head and neck cancers.
    Kulasinghe A; Kenny L; Punyadeera C
    Oral Oncol; 2017 Dec; 75():6-7. PubMed ID: 29224824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial cells in the peripheral blood of patients with cancer of the head and neck: incidence, detection and possible clinical significance.
    Pajonk F; Schlessmann S; Guttenberger R; Henke M
    Radiother Oncol; 2001 May; 59(2):213-7. PubMed ID: 11325451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum biomarkers in head and neck squamous cell cancer.
    Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
    JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction.
    Brakenhoff RH; Stroomer JG; ten Brink C; de Bree R; Weima SM; Snow GB; van Dongen GA
    Clin Cancer Res; 1999 Apr; 5(4):725-32. PubMed ID: 10213205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma.
    Van Hal NL; Van Dongen GA; Ten Brink CB; Heider KH; Rech-Weichselbraun I; Snow GB; Brakenhoff RH
    Clin Cancer Res; 1999 Nov; 5(11):3534-41. PubMed ID: 10589769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.